Cleveland BioLabs Q3 EPS $(0.04) Up From $(0.1) YoY

Cleveland BioLabs (NASDAQ:CBLI) reported quarterly losses of $(0.04) per share. This is a 60 percent increase over losses of $(0.1) per share from the same period last year.

Benzinga · 11/14/2019 21:34

Cleveland BioLabs (NASDAQ:CBLI) reported quarterly losses of $(0.04) per share. This is a 60 percent increase over losses of $(0.1) per share from the same period last year.